The interface between claim scope and sufficiency has increasingly come under the spotlight in recent years. When can a broad claim be justified as providing legitimate protection for a principle of general application, and when should such a claim fall for lack of sufficiency? In this webinar we will review the key EPO and UK cases in this field and further consider to what extent the recent UK Supreme Court decision in Regeneron v Kymab moves the dial in this regard.
Topics will include:
This is a technical webinar aimed at:
This webinar is available on-demand
Ravi Srinivasan, Partner, Patent Attorney, J A Kemp
Ravi has over 20 years of professional experience. He is known for his practical and commercial approach to patent work. He handles cases in both organic and inorganic chemistry, with particular expertise in the pharmaceutical field where he advises startup companies as well as medium-sized and large pharmaceutical companies.
Chris Milton, Partner, Patent Attorney
Chris handles patent work covering a broad range of chemical technologies, but has particular expertise in the pharmaceutical area. He is experienced in filing and prosecuting SPCs and patent term extensions for pharmaceutical products throughout the world. Chris has considerable experience of attacking and defending patents at the European Patent Office and has been involved in several high profile cases in the anti-viral field.
To book please visit the registration page.
